IRON OXIDE-BASED CONTRAST AGENTS AFFECT THE FATE OF PROFESSIONAL PHAGOCYTES

被引：0
|
作者：
Simmet, T.
Syrovets, T.
机构：
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2014年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
1155
引用
收藏
页码：359 / 359
页数：1
相关论文
共 50 条
  • [1] Red Blood Cells as Carriers of Iron Oxide-Based Contrast Agents for Diagnostic Applications
    Antonelli, Antonella
    Magnani, Mauro
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2014, 10 (09) : 1732 - 1750
  • [2] Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes
    Lunov, Oleg
    Syrovets, Tatiana
    Roecker, Carlheinz
    Tron, Kyrylo
    Nienhaus, G. Ulrich
    Rasche, Volker
    Mailaender, Volker
    Landfester, Katharina
    Simmet, Thomas
    BIOMATERIALS, 2010, 31 (34) : 9015 - 9022
  • [3] Comparison of Two Different Iron Oxide-Based Contrast Agents for Discrimination of Benign and Malignant Lymph Nodes
    Kinner, Sonja
    Maderwald, Stefan
    Albert, Juliane
    Parohl, Nina
    Corot, Claire
    Robert, Philippe
    Baba, Hideo A.
    Barkhausen, Joerg
    INVESTIGATIVE RADIOLOGY, 2012, 47 (09) : 511 - 515
  • [4] Accumulation of Iron Oxide-Based Contrast Agents in Rabbit Atherosclerotic Plaques in Relation to Plaque Age and Vulnerability Features
    Sekita, Alexander
    Unterweger, Harald
    Berg, Sonja
    Ohlmeyer, Sabine
    Baeuerle, Tobias
    Zheng, Kang H.
    Coolen, Bram F.
    Nederveen, Aart J.
    Cabella, Claudia
    Rossi, Silvia
    Stroes, Erik S. G.
    Alexiou, Christoph
    Lyer, Stefan
    Cicha, Iwona
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 1645 - 1666
  • [5] Comparison of commercial iron oxide-based MRI contrast agents with synthesized high-performance MPI tracers
    Luedtke-Buzug, Kerstin
    Haegele, Julian
    Biederer, Sven
    Sattel, Timo F.
    Erbe, Marlitt
    Duschka, Robert L.
    Barkhausen, Joerg
    Vogt, Florian M.
    BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK, 2013, 58 (06): : 527 - 533
  • [6] Shape-dependent cellular behaviors and relaxivity of iron oxide-based T1 MRI contrast agents
    Sherwood, J.
    Lovas, K.
    Rich, M.
    Yin, Q.
    Lackey, K.
    Bolding, M. S.
    Bao, Y.
    NANOSCALE, 2016, 8 (40) : 17506 - 17515
  • [7] Comparison of the Pharmacokinetics of Gadolinium-Based and Iron Oxide-Based Contrast Agents inside the Lymphatic Structure using Magnetic Resonance Lymphangiography
    Chae, Yeon Ji
    Kim, Kyung Won
    Kim, Mi-hyun
    Woo, Chul-Woong
    Kim, Sang-Tae
    Kim, Ji-wook
    Shin, Tae-Hyun
    Lee, Do-Wan
    Kim, Jeong Kon
    Choi, Yoonseok
    Woo, Dong-Cheol
    MOLECULAR IMAGING AND BIOLOGY, 2024, 26 (04) : 638 - 648
  • [8] Comparative in vitro and in vivo Evaluation of Different Iron Oxide-Based Contrast Agents to Promote Clinical Translation in Compliance with Patient Safety
    Unterweger, Harald
    Janko, Christina
    Folk, Tamara
    Cicha, Iwona
    Kovacs, Noemi
    Gyebnar, Gyula
    Horvath, Ildiko
    Mathe, Domokos
    Zheng, Kang H.
    Coolen, Bram F.
    Stroes, Erik
    Szebeni, Janos
    Alexiou, Christoph
    Dezsi, Laszlo
    Lyer, Stefan
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 2071 - 2086
  • [9] Iron oxide-based nanomaterials for supercapacitors
    Xu, Bingyan
    Zheng, Mingbo
    Tang, Hao
    Chen, Zixia
    Chi, Yao
    Wang, Lei
    Zhang, Lan
    Chen, Yiyi
    Pang, Huan
    NANOTECHNOLOGY, 2019, 30 (20)
  • [10] Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging
    Shen, Zheyu
    Wu, Aiguo
    Chen, Xiaoyuan
    MOLECULAR PHARMACEUTICS, 2017, 14 (05) : 1352 - 1364
12345